waltham

GSK Acquires Tesaro in a USD 5.1 Billion Deal

GSK Acquires Tesaro in a USD 5.1 Billion Deal

GlaxoSmithKline (NYSE: GSK) announced on Monday that it will acquire Tesaro (NASDAQ: TSRO) for USD 5.1 Billion.This marks the first big acquisition since Hal Barron, a pharma veteran and experienced scientist took on the role of chief scientific off..